MFS
VRNA

Mirabella Financial Services’s Verona Pharma VRNA Stock Holding History

Mirabella Financial Services’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-29,383
Closed -$10.4M – 673
2023
Q1 		$10.4M Sell
29,383
-16,540
-36% -$357K 1.57% 9
2022
Q4 		$1.2M Buy
+45,923
New +$612K 0.11% 128

Other funds holding VRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Mirabella Financial Services's VRNA Position: Q2 2023 in Review

Mirabella Financial Services sold out of Verona Pharma (VRNA) in Q2 2023, closing a stake of 29,383 shares — an estimated $10.4M sold.

Mirabella Financial Services first reported a position in VRNA in Q4 2022 and held it in 2 quarters. The position peaked at $10.4M in Q1 2023. 105 funds tracked by Wall St. Rank hold VRNA as of Q2 2023.

  • Mirabella Financial Services reported no remaining Verona Pharma position as of Q2 2023 after selling out during the quarter.
  • Mirabella Financial Services sold 29,383 Verona Pharma shares in Q2 2023, an estimated $10.4M.
  • Mirabella Financial Services first reported a position in Verona Pharma in Q4 2022 and held it in 2 quarters.
  • Mirabella Financial Services's Verona Pharma position peaked at $10.4M in Q1 2023.
  • 105 funds tracked by Wall St. Rank held Verona Pharma as of Q2 2023.

Based on Mirabella Financial Services's 13F filing for Q2 2023, filed 7 Aug 2023.